Skip Navigation


Rheumatology Advance Access originally published online on July 17, 2007
Rheumatology 2007 46(11):1641-1647; doi:10.1093/rheumatology/kem158
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/11/1641    most recent
kem158v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Uthman, I.
Right arrow Articles by Khamashta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uthman, I.
Right arrow Articles by Khamashta, M.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

REVIEWS

The abdominal manifestations of the antiphospholipid syndrome

I. Uthman and M. Khamashta1

Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon and 1Lupus Research Unit, The Rayne Institute, Guy's, King's and St Thomas’ School of Medicine, St. Thomas’ Hospital, London, UK

Correspondence to: Imad W. Uthman, MD, MPH, American University of Beirut, Medical Center, PO Box: 113-6044, Beirut, Lebanon. E-mail: iuthman{at}aub.edu.lb


  Abstract

Objectives. To study the abdominal manifestations of the antiphospholipid syndrome (APS).

Methods. We reviewed the medical literature from 1968 to 2006 using MEDLINE and the key words: APS, anticardiolipin antibodies, lupus anticoagulant, antiphospholipid (aPL) antibodies, catastrophic antiphospholipid syndrome, liver, hepatic biliary, pancreas, spleen, gastrointestinal and abdominal.

Results. Liver involvement is the most frequent abdominal manifestation associated with APS. Various hepatic manifestations have been reported including Budd-Chiari syndrome, hepatic-veno-occlusive disease and occlusion of small hepatic veins, nodular regenerative hyperplasia, hepatic infarction, cirrhosis, portal hypertension, autoimmune hepatitis and biliary cirrhosis. Acute intestinal infarction, intestinal angina, and intestinal bleeding have also been reported in association with aPL in addition to few sporadic cases of splenic infarction and acute pancreatitis.

Conclusion. A high index of suspicion for any signs of abdominal involvement should be considered in patients with APS. In addition screening for aPL should be carried out in patients who present with hepatic vein occlusion and unexplained signs of intestinal angina.

KEY WORDS: Anticardiolipin antibodies, Primary biliary cirrhosis, Primary sclerosing cholangitis, Antiphospholipid antibodies, Antiphospholipid syndrome, Autoimmune hepatitis

Submitted 1 March 2007; revised version accepted 18 May 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.